Skip to content
Screener

EyePoint, Inc. EYPT Short-Term Investments

Short-Term Investments at other companies

Merck & Co. logo
Merck & Co.MRK
$292M-52.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.54B+1.2%
Regenxbio logo
RegenxbioRGNX
$69.03M-71.7%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$318.4M+69.4%
KLR
Kalaris TherapeuticsKLRS
$62.79M
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$245.1M-13.8%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.2B+69.1%
Enterprise value$1.11B+67.9%
P/S429.4×+416×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037
Line itemJune 30, 2026December 31, 2025
Assets
Current assets:
Cash and cash equivalents$110,458$101,821
Marketable securities70,014204,265
Accounts and other receivables, net86651
Prepaid expenses and other current assets6,37720,105
Inventory1,8821,813
Total current assets188,817328,655

Item 1. Unaudited Financial Statements

FAQ

What is EyePoint, Inc.'s short-term investments?
EyePoint, Inc. (EYPT) reported short-term investments of $70.01M in Q2 2026.
How has EyePoint, Inc.'s short-term investments changed year-over-year?
EyePoint, Inc.'s short-term investments decreased by 62.1% year-over-year, from $184.59M to $70.01M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

Ask your AI about EyePoint, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude